유럽의 PCR 기술 시장 예측(-2030년) : 지역별 분석 - 기술, 제공, 용도, 최종사용자별

The Europe PCR technologies market is expected to grow from US$ 3,880.13 million in 2022 to US$ 7,173.73 million by 2030. It is estimated to record a CAGR of 8.0% from 2022 to 2030.

Increasing Adoption of PCR Techniques in Emerging Countries Drives Europe PCR Technologies Market

Point-of-care (POC) testing presents a significant opportunity for the PCR technology market by expanding its reach and applications. PCR technology, known for its accuracy and sensitivity, is increasingly being adapted for POC testing due to its ability to deliver rapid and reliable results at or near the point of care. As POC testing becomes more prevalent in healthcare settings such as clinics, emergency departments, and decentralized facilities, the demand for PCR platforms and assays tailored for POC applications is expected to rise.

PCR's advantages, including the ability to detect infectious diseases with high specificity and sensitivity, make it well-suited for POC testing, particularly in situations requiring rapid diagnosis and treatment decisions. Additionally, the miniaturization and automation of PCR systems further enable their integration into POC settings, facilitating on-site testing and improving patient care outcomes. As healthcare providers increasingly recognize the value of POC PCR testing in enhancing diagnostic capabilities and patient management, the market for POC PCR technologies is poised for growth and innovation.

Europe PCR Technologies Market Overview

The European PCR technologies market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Funds made available by government and private organizations for advanced research, the launch of innovative technologies for artificial DNA synthesis, and an increase in various research studies for novel technology-based applications drive the growth of the PCR technologies market in Europe. In addition, efforts taken by the national governments to encourage innovation through incentive provisions and tax exemptions for R&D and new biotech start-ups are expected to favour the European PCR technologies market growth over the forecast period. Germany is one of the largest biotechnology hubs in Europe and worldwide owing to the presence of prominent biotech players, high-tech research labs, and massive funding for conducting research and development activities in the new areas of science and technology. The country has more biotechnology companies than any other European country. The cutting-edge and high-quality research ongoing in Germany creates lucrative opportunities for the already established market for PCR technologies. Individual researchers and academic universities in the country collaborate with international laboratories and institutions to create breakthrough innovations. The rising funds and grants and increasing use of synthetic biology in various application areas are the major factors favoring the growth of the German PCR technologies market. The German government considers the formation of startups to be an essential part of the development of the biotechnology industry in the country. For instance, BIO Deutschland is a sector association of the German biotech industry based in Berlin, with over 330 members that promote and support the development of the industry to help it bloom as a robust economic entity. Similarly, Euronext is another organization that recognizes and utilizes the current momentum of the biotech industry. It thus assists startups by creating jobs, raising funds and investments, and supporting the companies in various other ways.

Europe PCR Technologies Market Revenue and Forecast to 2030 (US$ Million)

Europe PCR Technologies Market Segmentation

The Europe PCR technologies market is segmented into technology, offerings, application, end user, and country.

Based on technology, the Europe PCR technologies market is categorized into real time PCR, conventional PCR, reverse transcription, digital PCR, multiplex RTPCR, hot start PCR, and others. The real time PCR segment held the largest share of Europe PCR technologies market in 2022.

In terms of offerings, the Europe PCR technologies market is segmented into reagents & consumables, instruments, and software & services. The reagents & consumables segment held the largest share of Europe PCR technologies market in 2022. Further, reagents & consumables segment are categorized into reagents, vials size, and other consumables. Furthermore, vials size is segmented into 0.2ml to 2ml, 0.1 ml to 0.3 ml, 2 ml to 5ml, and other vials. Additionally, instruments segment is bifurcated into benchtop PCR, and portable thermocyclers/PCR.

By application, the Europe PCR technologies market is segmented into gene expression analysis, genetic sequencing, genotyping, nucleic acid synthesis, standard validation, point of care diagnostic application, environmental application, and others. The gene expression analysis segment held the largest share of Europe PCR technologies market in 2022.

Based on end user, the Europe PCR technologies market is segmented into hospitals & diagnostic centres, pharmaceutical & biotechnology companies, academic institutes & research laboratories, and others. The hospitals & diagnostic centres segment held the largest share of Europe PCR technologies market in 2022.

By country, the Europe PCR technologies market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe PCR technologies market in 2022.

Thermo Fisher Scientific Inc, Promega Corp, QIAGEN NV, bioMerieux SA, Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Becton Dickinson and Co, Takara Bio Inc, Standard Bio Tools Inc, Agilent Technologies Inc, and Ellume Ltd are some of the leading companies operating in the Europe PCR technologies market.

Table Of Contents

1. Introduction

• 1.1 The Insight Partners Research Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Coverage
• 3.2 Secondary Research
• 3.3 Primary Research

4. Europe PCR Technologies Market - Key Industry Dynamics

• 4.1 PCR Technologies Market - Key Industry Dynamics
• 4.2 Market Drivers
  • 4.2.1 Rising Prevalence of Genetic and Infectious Diseases
  • 4.2.2 Surging Investments and Funds Availability for PCR Technologies
• 4.3 Market Restraints
  • 4.3.1 High Costs of PCR Systems and Availability of Alternative Assays
• 4.4 Market Opportunities
  • 4.4.1 Increasing Demand for POC Testing
• 4.5 Future Trends
  • 4.5.1 Advancements in PCR Technologies
• 4.6 Impact of Drivers and Restraints:

5. PCR Technologies Market - Europe Market Analysis

• 5.1 PCR Technologies Market Revenue (US$ Million), 2020 - 2030

6. Europe PCR Technologies Market Analysis - By Technology

• 6.1 Overview
• 6.2 Real Time PCR
  • 6.2.1 Overview
  • 6.2.2 Real Time PCR Market, Revenue and Forecast to 2030 (US$ Million)
• 6.3 Conventional PCR
  • 6.3.1 Overview
  • 6.3.2 Conventional PCR Market, Revenue and Forecast to 2030 (US$ Million)
• 6.4 Reverse Transcription PCR
  • 6.4.1 Overview
  • 6.4.2 Reverse Transcription PCR Market, Revenue and Forecast to 2030 (US$ Million)
• 6.5 Digital PCR
  • 6.5.1 Overview
  • 6.5.2 Digital PCR Market, Revenue and Forecast to 2030 (US$ Million)
• 6.6 Multiplex RT PCR
  • 6.6.1 Overview
  • 6.6.2 Multiplex RT PCR Market, Revenue and Forecast to 2030 (US$ Million)
• 6.7 Hot Start PCR
  • 6.7.1 Overview
  • 6.7.2 Hot Start PCR Market, Revenue and Forecast to 2030 (US$ Million)
• 6.8 Others
  • 6.8.1 Overview
  • 6.8.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

7. Europe PCR Technologies Market Analysis - By Offerings

• 7.1 Overview
• 7.2 PCR Technologies Market Revenue Share, by Offerings 2022 & 2030 (%)
• 7.3 Reagents and Consumables
  • 7.3.1 Overview
  • 7.3.2 Reagents and Consumables Market, Revenue and Forecast to 2030 (US$ Million)
    • 7.3.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Reagents and Consumables
      • 7.3.2.1.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Vial Size
• 7.4 Instruments
  • 7.4.1 Overview
  • 7.4.2 Instruments Market, Revenue and Forecast to 2030 (US$ Million)
    • 7.4.2.1 PCR Technologies Market - Revenue and Forecast to 2030(US$ Million) - By Instruments
• 7.5 Software and Services
  • 7.5.1 Overview
  • 7.5.2 Software and Services Market, Revenue and Forecast to 2030 (US$ Million)

8. Europe PCR Technologies Market Analysis - By Application

• 8.1 Overview
• 8.2 PCR Technologies Market Revenue Share, by Application 2022 & 2030 (%)
• 8.3 Gene Expression Analysis
  • 8.3.1 Overview
  • 8.3.2 Gene Expression Analysis Market, Revenue and Forecast to 2030 (US$ Million)
• 8.4 Genetic Sequencing
  • 8.4.1 Overview
  • 8.4.2 Genetic Sequencing Market, Revenue and Forecast to 2030 (US$ Million)
• 8.5 Genotyping
  • 8.5.1 Overview
  • 8.5.2 Genotyping Market, Revenue and Forecast to 2030 (US$ Million)
• 8.6 Nucleic Acid Synthesis
  • 8.6.1 Overview
  • 8.6.2 Nucleic Acid Synthesis Market, Revenue and Forecast to 2030 (US$ Million)
• 8.7 Standard Validation
  • 8.7.1 Overview
  • 8.7.2 Standard Validation Market, Revenue and Forecast to 2030 (US$ Million)
• 8.8 Point of Care Diagnostics
  • 8.8.1 Overview
  • 8.8.2 Point of Care Diagnostics Market, Revenue and Forecast to 2030 (US$ Million)
• 8.9 Environmental Application
  • 8.9.1 Overview
  • 8.9.2 Environmental Application Market, Revenue and Forecast to 2030 (US$ Million)
• 8.10 Others
  • 8.10.1 Overview
  • 8.10.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

9. Europe PCR Technologies Market Analysis - By End User

• 9.1 Overview
• 9.2 PCR Technologies Market Revenue Share, by End User 2022 & 2030 (%)
• 9.3 Hospitals and Diagnostic Centers
  • 9.3.1 Overview
  • 9.3.2 Hospitals and Diagnostic Centers Market, Revenue and Forecast to 2030 (US$ Million)
• 9.4 Academia and Research Institutes
  • 9.4.1 Overview
  • 9.4.2 Academia and Research Institutes Market, Revenue and Forecast to 2030 (US$ Million)
• 9.5 Pharmaceutical and Biotechnology Companies
  • 9.5.1 Overview
  • 9.5.2 Pharmaceutical and Biotechnology Companies Market, Revenue and Forecast to 2030 (US$ Million)
• 9.6 Others
  • 9.6.1 Overview
  • 9.6.2 Others Market, Revenue and Forecast to 2030 (US$ Million)

10. Europe PCR Technologies Market -Country Analysis

• 10.1 Europe: PCR Technologies Market
  • 10.1.1 Overview
  • 10.1.2 Europe PCR Technologies Market Revenue and Forecast and Analysis - By Country
    • 10.1.2.1 Germany
      • 10.1.2.1.1 Overview
    • 10.1.2.2 Germany PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.2.1 Germany PCR Technologies Market Breakdown by Technology
      • 10.1.2.2.2 Germany PCR Technologies Market Breakdown by Offerings
      • 10.1.2.2.2.1 Germany PCR Technologies Market Breakdown by Instruments
      • 10.1.2.2.2.2 Germany PCR Technologies Market Breakdown by Reagents and Consumables
      • 10.1.2.2.2.2.1 Germany PCR Technologies Market Breakdown by Vial Size
      • 10.1.2.2.3 Germany PCR Technologies Market Breakdown by Application
      • 10.1.2.2.4 Germany PCR Technologies Market Breakdown by End User
    • 10.1.2.3 United Kingdom
      • 10.1.2.3.1 Overview
    • 10.1.2.4 United Kingdom PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.4.1 United Kingdom PCR Technologies Market Breakdown by Technology
      • 10.1.2.4.2 United Kingdom PCR Technologies Market Breakdown by Offerings
      • 10.1.2.4.2.1 United Kingdom PCR Technologies Market Breakdown by Instruments
      • 10.1.2.4.2.2 United Kingdom PCR Technologies Market Breakdown by Reagents and Consumables
      • 10.1.2.4.2.2.1 United Kingdom PCR Technologies Market Breakdown by Vial Size
      • 10.1.2.4.3 United Kingdom PCR Technologies Market Breakdown by Application
      • 10.1.2.4.4 United Kingdom PCR Technologies Market Breakdown by End User
    • 10.1.2.5 France
      • 10.1.2.5.1 Overview
    • 10.1.2.6 France PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.6.1 France PCR Technologies Market Breakdown by Offerings
      • 10.1.2.6.1.1 France PCR Technologies Market Breakdown by Instruments
      • 10.1.2.6.1.2 France PCR Technologies Market Breakdown by Reagents and Consumables
      • 10.1.2.6.1.2.1 France PCR Technologies Market Breakdown by Vial Size
      • 10.1.2.6.2 France PCR Technologies Market Breakdown by Application
      • 10.1.2.6.3 France PCR Technologies Market Breakdown by End User
    • 10.1.2.7 Italy
      • 10.1.2.7.1 Overview
    • 10.1.2.8 Italy PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.8.1 Italy PCR Technologies Market Breakdown by Technology
      • 10.1.2.8.2 Italy PCR Technologies Market Breakdown by Offerings
      • 10.1.2.8.2.1 Italy PCR Technologies Market Breakdown by Instruments
      • 10.1.2.8.2.2 Italy PCR Technologies Market Breakdown by Reagents and Consumables
      • 10.1.2.8.2.2.1 Italy PCR Technologies Market Breakdown by Vial Size
      • 10.1.2.8.3 Italy PCR Technologies Market Breakdown by Application
      • 10.1.2.8.4 Italy PCR Technologies Market Breakdown by End User
    • 10.1.2.9 Spain
      • 10.1.2.9.1 Overview
    • 10.1.2.10 Spain PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.10.1 Spain PCR Technologies Market Breakdown by Technology
      • 10.1.2.10.2 Spain PCR Technologies Market Breakdown by Offerings
      • 10.1.2.10.2.1 Spain PCR Technologies Market Breakdown by Instruments
      • 10.1.2.10.2.2 Spain PCR Technologies Market Breakdown by Reagents and Consumables
      • 10.1.2.10.2.2.1 Spain PCR Technologies Market Breakdown by Vial Size
      • 10.1.2.10.3 Spain PCR Technologies Market Breakdown by Application
      • 10.1.2.10.4 Spain PCR Technologies Market Breakdown by End User
    • 10.1.2.11 Rest of Europe
      • 10.1.2.11.1 Overview
    • 10.1.2.12 Rest of Europe PCR Technologies Market Revenue and Forecast to 2030 (US$ Mn)
      • 10.1.2.12.1 Rest of Europe PCR Technologies Market Breakdown by Technology
      • 10.1.2.12.2 Rest of Europe PCR Technologies Market Breakdown by Offerings
      • 10.1.2.12.2.1 Rest of Europe PCR Technologies Market Breakdown by Instruments
      • 10.1.2.12.2.2 Rest of Europe PCR Technologies Market Breakdown by Reagents and Consumables
      • 10.1.2.12.2.2.1 Rest of Europe PCR Technologies Market Breakdown by Vial Size
      • 10.1.2.12.3 Rest of Europe PCR Technologies Market Breakdown by Application
      • 10.1.2.12.4 Rest of Europe PCR Technologies Market Breakdown by End User

11. PCR Technologies Market-Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in the PCR Technologies Market
• 11.3 Inorganic Growth Strategies
  • 11.3.1 Overview
• 11.4 Organic Growth Strategies
  • 11.4.1 Overview

12. Company Profiles

• 12.1 Thermo Fisher Scientific Inc
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 Promega Corp
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 QIAGEN NV
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 bioMerieux SA
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 Hoffmann-La Roche Ltd
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 Bio-Rad Laboratories Inc
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
• 12.7 Becton Dickinson and Co
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Products and Services
  • 12.7.4 Financial Overview
  • 12.7.5 SWOT Analysis
  • 12.7.6 Key Developments
• 12.8 Takara Bio Inc
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
• 12.9 Standard Biotools Inc
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
• 12.10 Agilent Technologies Inc
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments
• 12.11 Ellume Ltd
  • 12.11.1 Key Facts
  • 12.11.2 Business Description
  • 12.11.3 Products and Services
  • 12.11.4 Financial Overview
  • 12.11.5 SWOT Analysis
  • 12.11.6 Key Developments

13. Appendix

• 13.1 About the Insight Partners
• 13.2 Glossary of Terms